Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Eher Negativ
- Seit dem 27.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 243,15 263 | 243,15 | 263 | 8,208188 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 243,15 250 | 243,15 | 250 | 2,859494 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 243,15 275 | 243,15 | 275 | 13,145443 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 243,15 250 | 243,15 | 250 | 2,859494 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 243,15 300 | 243,15 | 300 | 23,431393 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 243,15 250 | 243,15 | 250 | 2,859494 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 243,15 260 | 243,15 | 260 | 6,973874 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 243,15 250 | 243,15 | 250 | 2,859494 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 243,15 332 | 243,15 | 332 | 36,597408 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 243,15 275 | 243,15 | 275 | 13,145443 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 243,15 275 | 243,15 | 275 | 13,145443 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 243,15 250 | 243,15 | 250 | 2,859494 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 243,15 275 | 243,15 | 275 | 13,145443 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 243,15 332 | 243,15 | 332 | 36,597408 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 243,15 332 | 243,15 | 332 | 36,597408 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 243,15 390 | 243,15 | 390 | 60,460811 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 243,15 436 | 243,15 | 436 | 79,386957 | GOLDMAN SACHS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 243,15 415 | 243,15 | 415 | 70,74676 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 243,15 390 | 243,15 | 390 | 60,460811 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 243,15 390 | 243,15 | 390 | 60,460811 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 243,15 415 | 243,15 | 415 | 70,74676 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 243,15 390 | 243,15 | 390 | 60,460811 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 243,15 360 | 243,15 | 360 | 48,117671 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 243,15 295 | 243,15 | 295 | 21,374203 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 243,15 295 | 243,15 | 295 | 21,374203 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 243,15 350 | 243,15 | 350 | 44,003292 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 243,15 352 | 243,15 | 352 | 44,826167 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 243,15 295 | 243,15 | 295 | 21,374203 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 243,15 270 | 243,15 | 270 | 11,088253 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 243,15 375 | 243,15 | 375 | 54,289241 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 243,15 315 | 243,15 | 315 | 29,602962 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 243,15 353 | 243,15 | 353 | 45,237605 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 243,15 500 | 243,15 | 500 | 105,718988 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 243,15 500 | 243,15 | 500 | 105,718988 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 243,15 290 | 243,15 | 290 | 19,317013 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 243,15 375 | 243,15 | 375 | 54,289241 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 243,15 391 | 243,15 | 391 | 60,872249 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 243,15 | 243,15 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 243,15 315 | 243,15 | 315 | 29,602962 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 243,15 400 | 243,15 | 400 | 64,57519 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 475 | 243,15 | 475 | 95,433038 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 243,15 600 | 243,15 | 600 | 146,862785 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 243,15 | 243,15 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 243,15 315 | 243,15 | 315 | 29,602962 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 243,15 315 | 243,15 | 315 | 29,602962 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 243,15 600 | 243,15 | 600 | 146,862785 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 243,15 391 | 243,15 | 391 | 60,872249 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 243,15 540 | 243,15 | 540 | 122,176507 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 243,15 290 | 243,15 | 290 | 19,317013 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 243,15 500 | 243,15 | 500 | 105,718988 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 243,15 500 | 243,15 | 500 | 105,718988 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 243,15 290 | 243,15 | 290 | 19,317013 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 243,15 340 | 243,15 | 340 | 39,888912 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 243,15 540 | 243,15 | 540 | 122,176507 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 243,15 315 | 243,15 | 315 | 29,602962 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M